webinar register page

Does the Evidence Support the Hype? COVID-19 and Antiviral Treatments
The magnitude of the COVID-19 pandemic globally is generating considerable interest in options to prevent infection and minimize the impact if infection occurs. Pre-exposure prophylaxis and post-exposure treatment with a group of drugs called antivirals, sometimes in combination with an antibiotic, have been the subject of public debate and at times significant media reporting. Join us for the evidence on two specific antiviral treatments that have been widely discussed — hydroxychloroquine (with or without the antibiotic azithromycin) and remdesivir. You’ll also learn about the clinical trials under way on the use of antivirals in preventing and treating COVID-19.

May 29, 2020 12:00 PM in Eastern Time (US and Canada)

Webinar logo
* Required information
Loading